Potassium canrenoate - Heart failure

You are here : Home > Formulary Search > Potassium canrenoate - Heart failure

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Injection

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

Guidelines

SPC

Restrictions / Comments :

Important

ASPH use in NEONATES only.

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Potassium canrenoate

Indication :

Heart failure

Group Name :

Keywords :

diuresis, aldosterone antagonist

Brand Names Include :

Important Information :

For use in patients who are unable to have oral spironolactone.

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Heart failure

Supporting Documents :

Other Indications

Below are listed other indications that Potassium canrenoate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Heart failure.

Committee Recommendations (0)

No records returned.